Acme United’s Record 2025 Strengthens Long-Term Outlook; Buy Rating Reaffirmed

In 2025, Acme United Corporation (US: ACU – $43.41) delivered record sales and earnings, achieving the strongest financial performance in its history despite a year marked by volatility and uncertainty. The Company navigated tariff disruptions, shifting customer demand, and global supply chain challenges to produce improved results across most of its key metrics. Several initiatives strengthened the Company’s long-term competitive […]

Read more

Acme United Corporation Achieves Its Best Year Ever Amid Tariff Volatility

In 2025, Acme United Corporation (US: ACU – $42.50) delivered record sales and earnings, achieving the strongest financial performance in its history despite a year marked by volatility and uncertainty. The Company navigated tariff disruptions, shifting customer demand, and global supply chain challenges to produce improved results across most of its key metrics. For the quarter ended December 31, 2025, […]

Read more

Acme United Leverages My Medic Acquisition at Record-Breaking SHOT Show

The 48th SHOT Show® officially opened at The Venetian Expo and Caesars Forum, marking the start of a highly influential week for the global firearm and outdoor industries. The four-day event, held January 20–23, drew more than 53,000 industry professionals and underscored the continued strength and reach of the sector. The sold-out show encompassed more than 830,000 net square feet […]

Read more

Acme United Closes Biggest Acquisition To Date

Acme United Corporation (US: ACU – $42.27) has taken a major strategic step with the acquisition of the assets of SLED Distribution, LLC, which operates under the brand name “My Medic.” The transaction represents the largest acquisition in Acme United’s history to date and significantly strengthens the Company’s position in the growing market for tactical, trauma, and emergency response products. […]

Read more

Acme United Europe Showcases Growth Ambitions at Medica 2025

Acme United’s (US: ACU – $40.46) European team made a strong impression at this year’s Medica 2025 show, where it exhibited its portfolio of medical products to thousands of industry professionals. With a dedicated booth at the leading medical trade fair, the team placed a particular emphasis on the expansion of its First Aid Only brand, a central pillar of […]

Read more

Earnings Mislead, Fundamentals Don’t: Acme United’s Q3 Highlights Underlying Strength

Acme United Corporation (US: ACU – $36.84), a leading provider of cutting, measuring, and safety products, revealed a 14 percent decrease in net income for the third quarter ended September 30, 2025, compared with the same period in 2024. While this figure might suggest a downturn in profitability, the decline was due to a one-time tax benefit recorded in the […]

Read more

2025 NSC Safety Congress & Expo: A Showcase of Innovation for Acme United Corp

The 2025 NSC Safety Congress & Expo, held in Denver, Colorado, once again brought together thousands of safety professionals, product innovators, and industry leaders under one roof to explore the next generation of workplace safety. As the flagship conference of the National Safety Council, the event combined a robust educational program, networking events, a dynamic expo floor, and a spotlight […]

Read more

Acme United Shows Strong Resilience in Second Quarter

Acme United’s (US: ACU – $40.13) second quarter results offer a clear message to investors: the Company is not only navigating challenges but leveraging them to build a more agile, efficient, and future-ready enterprise. While net sales dipped 3% year-over-year to $54.0 million from $55.4 million, net income climbed 7%, reaching $4.8 million, or $1.16 per diluted share, compared to […]

Read more

Acme United Turns Tariff Pressure into Strategic Win

In its second quarter of 2025, Acme United Corporation (US: ACU – $43.28) demonstrated resilience and strategic agility, reporting increased profitability despite a modest decline in revenue. While net sales dipped 3% year-over-year to $54.0 million from $55.4 million, net income climbed 7%, reaching $4.8 million, or $1.16 per diluted share, compared to $1.09 per share in the same period […]

Read more
1 2 3 26